# CELDARA MEDICAL, LLC: Development of a Novel, Allogeneic Cell Therapy for Difficult to Treat IBD

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | CELDARA MEDICAL, LLC |
| Location | LEBANON, NH |
| Project | Development of a Novel, Allogeneic Cell Therapy for Difficult to Treat IBD |
| Project number | 1R43DK143897-01A1 |
| Mechanism | R43 |
| Institute | National Institute of Diabetes and Digestive and Kidney Diseases |
| Award | $356,328 |
| Awarded | 2026-08-28 |
| Project period | 2026-09-01 to 2027-08-31 |
| UEI | MMVKQXZUBMQ7 |

## Why this score
- Award of $356,328.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11312520). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.